- Ring The Bell
- Posts
- 😲 Why The Market Could Suffer A 'Real Correction'
😲 Why The Market Could Suffer A 'Real Correction'
Plus, discover the market's hidden gems, and more
You're receiving this email because you're subscribed to Ring the Bell from Benzinga. To manage your subscription, click the link at the bottom of this email.
Happy Wednesday! Markets are showing signs of a deeper pullback, with rising volatility and fading consumer confidence fueling correction concerns. Here’s what investors should watch — and how defensive positioning could pay off. Also, extract compelling ideas from the fringes of the market.
—Josh Enomoto
Plus, if you’re interested in conducting deep dives into biotech companies, check out today’s sponsor.
MARKET RECAP
Last week: Stocks closed little changed Tuesday, with the S&P 500 edging up 0.2% while the Dow and Nasdaq hovered near the flatline. Energy and materials stocks led gains, fueled by a spike in oil prices, while bond yields climbed as the 10-year Treasury yield hit 4.55%. Investors remain focused on corporate earnings strength and broader economic conditions as markets navigate ongoing uncertainties.
On Our Radar: Economists will turn to new home sales for additional clues about broader health before assessing tomorrow’s initial jobless claims. On the earnings front, semiconductor juggernaut Nvidia will dominate business headlines after the close.
TOP STORY
The market’s recent turbulence has some experts warning of a long-overdue correction, as investors grow cautious amid weakening consumer sentiment.
SPONSORED CONTENT
Get real-time access to detailed insights on ongoing trials, key milestones and upcoming results. Covering 900+ biotech companies and tracking 7,000+ clinical trials, our platform now integrates with Trial Insights for in-depth information on sponsors, locations, endpoints, and more.
Receive instant notifications via desktop or email about new data, trials, and updates.
This is a paid ad. Please see 17b disclosure here for more information.
FIVE ZINGERS
Super Rise: Tech giant Super Micro Computer shares surged in Tuesday's after-hours session. Read the regulatory news that reignited positive momentum.
Big Screen: AMC posted Q4 results on Tuesday, delivering estimate-beating revenue of $1.31 billion. Learn why management is excited about the coming year.
New Mobility: Lucid reported its Q4 earnings, generating revenue of $234.5 million and beating the consensus view. Discover the high-level changes that are underway.
Confidence Vote: Goldman Sachs analyst Kash Rangan reiterated a Buy rating on Microsoft while also boosting the price target to $500. Here's why the expert is so confident in a momentum swing.
Novel Drug: Enveric Biosciences saw its shares skyrocket after securing its first U.S. patent. Learn how non-psychedelic compounds could potentially treat addiction and ADHD.
SPECIAL OFFER
Editor’s Note: Every Tuesday, Benzinga Edge members receive the Under the Radar pick, detailing a very profitable stock or market trend that no one’s talking about. Here’s a sneak peek at yesterday’s:
We do not want to find ourselves in a situation like Yogi Berra once described a New York hangout—a place that no one goes to anymore because it is too crowded. We aim to bring you companies that are undervalued and selling for a fraction of their intrinsic worth as operating businesses, long before the thundering herd begins piling into the shares.
Occasionally, we identify a business that Wall Street is ignoring, which is trading for less than the value of its assets but has the financial strength to survive until conditions improve or until an acquisition occurs. Fast-growing companies that Wall Street has not yet discovered are another valuable source of potentially profitable ideas.
Sometimes, we introduce the names of hedge fund managers who work outside the spotlight yet consistently generate market-beating returns. Cloning their portfolios, away from the bright lights of Wall Street, can be profitable.
You have probably also noticed that I am country-agnostic. For the most part, I do not care where a business is located. If research shows that it has the potential for substantial profits, I want to share it with you.
My favorite thing to share with readers is a strategy that Wall Street is not discussing but has the potential to deliver significant winners. Those who have followed me for any length of time know that I am constantly testing ideas and strategies to determine what works and what does not.
Get all the details from yesterday’s Benzinga Edge-exclusive Under the Radar report. Click here to get a sneak peek.
SPECIAL OFFER
Big market swings create big trading opportunities—if you have the right strategy. Join Nic Chahine live on Wednesday, February 26, at 6 PM ET as he breaks down the latest market shifts and shares his top short-term trading setups for high-volatility conditions. Reserve your spot now!
BEFORE YOU GO
Were you forwarded this email? Click here to subscribe.
And be sure to check out our other newsletters:
Future Finance: Where fintech, crypto and the future of finance collide. Future Finance is a perfect lunch read packed with quick bites for industry enthusiasts. Subscribe here.
Cannabis Daily: A must-read daily briefing for cannabis investors, operators and enthusiasts. Join our list of industry veterans to jump start your morning. Subscribe here.
Advisor: Tailor-made for Financial Advisors, this weekly newsletter has industry-specific insights, analysis and news. Subscribe here.
Tech Trends: Get the inside scoop on AI, the hottest gadgets and mind-blowing tech trends. Subscribe here.